ID   SMUF1_HUMAN             Reviewed;         757 AA.
AC   Q9HCE7; A4D279; B7ZMB6; B9EGV3; O75853; Q547Q3; Q9UJT8;
DT   13-DEC-2001, integrated into UniProtKB/Swiss-Prot.
DT   13-DEC-2001, sequence version 2.
DT   15-MAR-2017, entry version 162.
DE   RecName: Full=E3 ubiquitin-protein ligase SMURF1;
DE            Short=hSMURF1;
DE            EC=2.3.2.26 {ECO:0000269|PubMed:19937093};
DE   AltName: Full=HECT-type E3 ubiquitin transferase SMURF1;
DE   AltName: Full=SMAD ubiquitination regulatory factor 1;
DE   AltName: Full=SMAD-specific E3 ubiquitin-protein ligase 1;
GN   Name=SMURF1; Synonyms=KIAA1625;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
RC   TISSUE=Brain;
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes.
RT   XVIII. The complete sequences of 100 new cDNA clones from brain which
RT   code for large proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Liang M., Lin X., Feng X.-H.;
RT   "Smurf1-beta, an alternatively spliced variant of Smad-ubiquitin E3
RT   ligase Smurf1.";
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS LONG AND SHORT).
RC   TISSUE=Brain, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 10-731 (ISOFORM SHORT), AND FUNCTION.
RX   PubMed=10458166; DOI=10.1038/23293;
RA   Zhu H., Kavsak P., Abdollah S., Wrana J.L., Thomsen G.H.;
RT   "A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic
RT   pattern formation.";
RL   Nature 400:687-693(1999).
RN   [8]
RP   INTERACTION WITH SMAD7 AND TGFBR1.
RX   PubMed=11163210; DOI=10.1016/S1097-2765(00)00134-9;
RA   Kavsak P., Rasmussen R.K., Causing C.G., Bonni S., Zhu H.,
RA   Thomsen G.H., Wrana J.L.;
RT   "Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the
RT   TGF-beta receptor for degradation.";
RL   Mol. Cell 6:1365-1375(2000).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS OF CYS-725, AND INTERACTION
RP   WITH TRAF4.
RX   PubMed=19937093; DOI=10.1007/s11010-009-0315-y;
RA   Li S., Lu K., Wang J., An L., Yang G., Chen H., Cui Y., Yin X.,
RA   Xie P., Xing G., He F., Zhang L.;
RT   "Ubiquitin ligase Smurf1 targets TRAF family proteins for
RT   ubiquitination and degradation.";
RL   Mol. Cell. Biochem. 338:11-17(2010).
RN   [10]
RP   SUBCELLULAR LOCATION, UBIQUITINATION AT LYS-381 AND LYS-383,
RP   INTERACTION WITH FBXL15, AND MUTAGENESIS OF LYS-350; LYS-381; LYS-383
RP   AND CYS-725.
RX   PubMed=21572392; DOI=10.1038/emboj.2011.155;
RA   Cui Y., He S., Xing C., Lu K., Wang J., Xing G., Meng A., Jia S.,
RA   He F., Zhang L.;
RT   "SCF(FBXL15) regulates BMP signalling by directing the degradation of
RT   HECT-type ubiquitin ligase Smurf1.";
RL   EMBO J. 30:2675-2689(2011).
RN   [11]
RP   FUNCTION, INTERACTION WITH MAVS, AND AUTO-UBIQUITINATION.
RX   PubMed=23087404; DOI=10.4049/jimmunol.1201445;
RA   Wang Y., Tong X., Ye X.;
RT   "Ndfip1 negatively regulates RIG-I-dependent immune signaling by
RT   enhancing E3 ligase Smurf1-mediated MAVS degradation.";
RL   J. Immunol. 189:5304-5313(2012).
RN   [12]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=23999003; DOI=10.1016/j.jdermsci.2013.07.010;
RA   Yoo J.C., Lim T.Y., Park J.S., Hah Y.S., Park N., Hong S.G.,
RA   Park J.Y., Yoon T.J.;
RT   "SYT14L, especially its C2 domain, is involved in regulating
RT   melanocyte differentiation.";
RL   J. Dermatol. Sci. 72:246-251(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-200, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.96 ANGSTROMS) OF 13-140, FUNCTION, DOMAIN C2,
RP   INTERACTION WITH RHOA, AND MUTAGENESIS OF LYS-28 AND LYS-85.
RX   PubMed=21402695; DOI=10.1074/jbc.M110.211979;
RA   Lu K., Li P., Zhang M., Xing G., Li X., Zhou W., Bartlam M., Zhang L.,
RA   Rao Z., He F.;
RT   "Pivotal role of the C2 domain of the Smurf1 ubiquitin ligase in
RT   substrate selection.";
RL   J. Biol. Chem. 286:16861-16870(2011).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that acts as a negative
CC       regulator of BMP signaling pathway. Mediates ubiquitination and
CC       degradation of SMAD1 and SMAD5, 2 receptor-regulated SMADs
CC       specific for the BMP pathway. Promotes ubiquitination and
CC       subsequent proteasomal degradation of TRAF family members and
CC       RHOA. Promotes ubiquitination and subsequent proteasomal
CC       degradation of MAVS (PubMed:23087404). Plays a role in dendrite
CC       formation by melanocytes (PubMed:23999003).
CC       {ECO:0000269|PubMed:10458166, ECO:0000269|PubMed:19937093,
CC       ECO:0000269|PubMed:21402695, ECO:0000269|PubMed:23087404,
CC       ECO:0000269|PubMed:23999003}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000269|PubMed:19937093}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with TRAF4. Interacts (via HECT domain) with
CC       FBXL15 (via LRR repeats). Interacts with SMAD7 and TGFBR1; SMAD7
CC       recruits SMURF1 to TGFBR1 and regulates TGF-beta receptor
CC       degradation. Interacts with MAVS; the interaction is mediated by
CC       NDFIP1 (PubMed:23087404). {ECO:0000269|PubMed:11163210,
CC       ECO:0000269|PubMed:19937093, ECO:0000269|PubMed:21402695,
CC       ECO:0000269|PubMed:21572392, ECO:0000269|PubMed:23087404}.
CC   -!- INTERACTION:
CC       O14757:CHEK1; NbExp=4; IntAct=EBI-9845742, EBI-974488;
CC       Q9H469:FBXL15; NbExp=6; IntAct=EBI-976466, EBI-6144096;
CC       Q9H160:ING2; NbExp=3; IntAct=EBI-9845742, EBI-389787;
CC       Q9Y5W3:KLF2; NbExp=4; IntAct=EBI-9845742, EBI-9846663;
CC       Q53GL0:PLEKHO1; NbExp=4; IntAct=EBI-9845742, EBI-949945;
CC       P61289:PSME3; NbExp=5; IntAct=EBI-976466, EBI-355546;
CC       P61586:RHOA; NbExp=2; IntAct=EBI-9845742, EBI-446668;
CC       P62745:RHOB; NbExp=3; IntAct=EBI-9845742, EBI-602647;
CC       Q15797:SMAD1; NbExp=2; IntAct=EBI-976466, EBI-1567153;
CC       Q9BUZ4:TRAF4; NbExp=4; IntAct=EBI-9845742, EBI-3650647;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21572392}.
CC       Cell membrane {ECO:0000269|PubMed:21572392}; Peripheral membrane
CC       protein {ECO:0000269|PubMed:21572392}; Cytoplasmic side
CC       {ECO:0000269|PubMed:21572392}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Long;
CC         IsoId=Q9HCE7-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=Q9HCE7-2; Sequence=VSP_006812;
CC   -!- TISSUE SPECIFICITY: Expressed in melanocytes (PubMed:23999003).
CC       {ECO:0000269|PubMed:23999003}.
CC   -!- DOMAIN: The C2 domain mediates membrane localization and substrate
CC       selection. {ECO:0000269|PubMed:21402695}.
CC   -!- PTM: Auto-ubiquitinated in presence of NDFIP1 (PubMed:23087404).
CC       Ubiquitinated by the SCF(FBXL15) complex at Lys-381 and Lys-383,
CC       leading to its degradation by the proteasome. Lys-383 is the
CC       primary ubiquitination site. {ECO:0000269|PubMed:21572392,
CC       ECO:0000269|PubMed:23087404}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB13451.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB046845; BAB13451.1; ALT_INIT; mRNA.
DR   EMBL; AC004893; AAC62434.1; -; Genomic_DNA.
DR   EMBL; AF464850; AAM90910.1; -; mRNA.
DR   EMBL; AC073468; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC114500; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH236956; EAL23885.1; -; Genomic_DNA.
DR   EMBL; CH236956; EAL23886.1; -; Genomic_DNA.
DR   EMBL; CH471091; EAW76687.1; -; Genomic_DNA.
DR   EMBL; CH471091; EAW76688.1; -; Genomic_DNA.
DR   EMBL; BC136804; AAI36805.1; -; mRNA.
DR   EMBL; BC144414; AAI44415.1; -; mRNA.
DR   EMBL; BC152468; AAI52469.1; -; mRNA.
DR   EMBL; AF199364; AAF08298.2; -; mRNA.
DR   CCDS; CCDS34689.1; -. [Q9HCE7-2]
DR   CCDS; CCDS34690.1; -. [Q9HCE7-1]
DR   RefSeq; NP_001186776.1; NM_001199847.1.
DR   RefSeq; NP_065162.1; NM_020429.2. [Q9HCE7-1]
DR   RefSeq; NP_851994.1; NM_181349.2. [Q9HCE7-2]
DR   UniGene; Hs.189329; -.
DR   PDB; 2LAZ; NMR; -; A=235-267.
DR   PDB; 2LB0; NMR; -; A=235-267.
DR   PDB; 2LB1; NMR; -; A=305-340.
DR   PDB; 2LTX; NMR; -; A=306-340.
DR   PDB; 3PYC; X-ray; 1.96 A; A=13-140.
DR   PDBsum; 2LAZ; -.
DR   PDBsum; 2LB0; -.
DR   PDBsum; 2LB1; -.
DR   PDBsum; 2LTX; -.
DR   PDBsum; 3PYC; -.
DR   ProteinModelPortal; Q9HCE7; -.
DR   SMR; Q9HCE7; -.
DR   BioGrid; 121411; 409.
DR   DIP; DIP-36709N; -.
DR   IntAct; Q9HCE7; 24.
DR   MINT; MINT-102628; -.
DR   STRING; 9606.ENSP00000354621; -.
DR   iPTMnet; Q9HCE7; -.
DR   PhosphoSitePlus; Q9HCE7; -.
DR   BioMuta; SMURF1; -.
DR   DMDM; 17865625; -.
DR   EPD; Q9HCE7; -.
DR   MaxQB; Q9HCE7; -.
DR   PaxDb; Q9HCE7; -.
DR   PeptideAtlas; Q9HCE7; -.
DR   PRIDE; Q9HCE7; -.
DR   Ensembl; ENST00000361125; ENSP00000354621; ENSG00000198742. [Q9HCE7-1]
DR   Ensembl; ENST00000361368; ENSP00000355326; ENSG00000198742. [Q9HCE7-2]
DR   GeneID; 57154; -.
DR   KEGG; hsa:57154; -.
DR   UCSC; uc003upu.3; human. [Q9HCE7-1]
DR   CTD; 57154; -.
DR   DisGeNET; 57154; -.
DR   GeneCards; SMURF1; -.
DR   HGNC; HGNC:16807; SMURF1.
DR   HPA; HPA055245; -.
DR   MIM; 605568; gene.
DR   neXtProt; NX_Q9HCE7; -.
DR   OpenTargets; ENSG00000198742; -.
DR   PharmGKB; PA134987175; -.
DR   eggNOG; KOG0940; Eukaryota.
DR   eggNOG; COG5021; LUCA.
DR   GeneTree; ENSGT00760000118966; -.
DR   HOGENOM; HOG000208451; -.
DR   HOVERGEN; HBG004134; -.
DR   InParanoid; Q9HCE7; -.
DR   KO; K04678; -.
DR   OMA; PYTDTTG; -.
DR   OrthoDB; EOG091G011S; -.
DR   PhylomeDB; Q9HCE7; -.
DR   TreeFam; TF323658; -.
DR   BRENDA; 2.3.2.B9; 2681.
DR   BRENDA; 6.3.2.19; 2681.
DR   Reactome; R-HSA-201451; Signaling by BMP.
DR   Reactome; R-HSA-2173788; Downregulation of TGF-beta receptor signaling.
DR   Reactome; R-HSA-2173791; TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition).
DR   Reactome; R-HSA-4608870; Asymmetric localization of PCP proteins.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; Q9HCE7; -.
DR   SIGNOR; Q9HCE7; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; SMURF1; human.
DR   EvolutionaryTrace; Q9HCE7; -.
DR   GeneWiki; SMURF1; -.
DR   GenomeRNAi; 57154; -.
DR   PRO; PR:Q9HCE7; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000198742; -.
DR   CleanEx; HS_SMURF1; -.
DR   Genevisible; Q9HCE7; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0048185; F:activin binding; NAS:BHF-UCL.
DR   GO; GO:0070411; F:I-SMAD binding; IPI:BHF-UCL.
DR   GO; GO:0005543; F:phospholipid binding; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0070412; F:R-SMAD binding; IPI:BHF-UCL.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:BHF-UCL.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0030509; P:BMP signaling pathway; IDA:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IDA:UniProtKB.
DR   GO; GO:0007398; P:ectoderm development; TAS:UniProtKB.
DR   GO; GO:0061736; P:engulfment of target by autophagosome; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0030514; P:negative regulation of BMP signaling pathway; TAS:UniProtKB.
DR   GO; GO:0030279; P:negative regulation of ossification; IEA:Ensembl.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0061734; P:parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization; IEA:Ensembl.
DR   GO; GO:1903861; P:positive regulation of dendrite extension; IDA:UniProtKB.
DR   GO; GO:2000060; P:positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IMP:CACAO.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:BHF-UCL.
DR   GO; GO:0006611; P:protein export from nucleus; IDA:BHF-UCL.
DR   GO; GO:0034394; P:protein localization to cell surface; IDA:BHF-UCL.
DR   GO; GO:0000209; P:protein polyubiquitination; IDA:UniProtKB.
DR   GO; GO:0072661; P:protein targeting to plasma membrane; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0071211; P:protein targeting to vacuole involved in autophagy; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:BHF-UCL.
DR   GO; GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0032801; P:receptor catabolic process; IDA:BHF-UCL.
DR   GO; GO:0061753; P:substrate localization to autophagosome; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0030579; P:ubiquitin-dependent SMAD protein catabolic process; IDA:BHF-UCL.
DR   GO; GO:0060071; P:Wnt signaling pathway, planar cell polarity pathway; TAS:Reactome.
DR   CDD; cd00078; HECTc; 1.
DR   Gene3D; 2.60.40.150; -; 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR000569; HECT_dom.
DR   InterPro; IPR001202; WW_dom.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF00632; HECT; 1.
DR   Pfam; PF00397; WW; 2.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00119; HECTc; 1.
DR   SMART; SM00456; WW; 2.
DR   SUPFAM; SSF49562; SSF49562; 1.
DR   SUPFAM; SSF51045; SSF51045; 2.
DR   SUPFAM; SSF56204; SSF56204; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS50237; HECT; 1.
DR   PROSITE; PS01159; WW_DOMAIN_1; 1.
DR   PROSITE; PS50020; WW_DOMAIN_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Complete proteome;
KW   Cytoplasm; Differentiation; Isopeptide bond; Membrane; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; Transferase;
KW   Ubl conjugation; Ubl conjugation pathway.
FT   CHAIN         1    757       E3 ubiquitin-protein ligase SMURF1.
FT                                /FTId=PRO_0000120326.
FT   DOMAIN        1     99       C2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   DOMAIN      234    267       WW 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00224}.
FT   DOMAIN      306    339       WW 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00224}.
FT   DOMAIN      420    757       HECT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00104}.
FT   ACT_SITE    725    725       Glycyl thioester intermediate.
FT   MOD_RES     200    200       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    381    381       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:21572392}.
FT   CROSSLNK    383    383       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:21572392}.
FT   VAR_SEQ     269    294       Missing (in isoform Short).
FT                                {ECO:0000303|PubMed:10458166,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_006812.
FT   VARIANT     466    466       S -> Y (in dbSNP:rs13246077).
FT                                /FTId=VAR_052959.
FT   MUTAGEN      28     28       K->A: Fails to ubiquitinate RHOA; when
FT                                associated with A-85.
FT                                {ECO:0000269|PubMed:21402695}.
FT   MUTAGEN      85     85       K->A: Fails to ubiquitinate RHOA; when
FT                                associated with A-28.
FT                                {ECO:0000269|PubMed:21402695}.
FT   MUTAGEN     350    350       K->R: Abolishes FBXL15-mediated
FT                                ubiquitination and degradation; when
FT                                associated with R-381 and R-381.
FT                                {ECO:0000269|PubMed:21572392}.
FT   MUTAGEN     381    381       K->R: Abolishes FBXL15-mediated
FT                                ubiquitination and degradation; when
FT                                associated with R-350 and R-383.
FT                                Abolishes FBXL15-mediated ubiquitination
FT                                and degradation; when associated with R-
FT                                383. {ECO:0000269|PubMed:21572392}.
FT   MUTAGEN     383    383       K->R: Abolishes FBXL15-mediated
FT                                ubiquitination and degradation; when
FT                                associated with R-350 and R-381.
FT                                Abolishes FBXL15-mediated ubiquitination
FT                                and degradation; when associated with R-
FT                                381. {ECO:0000269|PubMed:21572392}.
FT   MUTAGEN     725    725       C->A: Loss of enzyme activity, without
FT                                abolishing FBXL15-mediated
FT                                ubiquitination.
FT                                {ECO:0000269|PubMed:19937093,
FT                                ECO:0000269|PubMed:21572392}.
FT   CONFLICT    447    447       W -> G (in Ref. 6; AAI44415).
FT                                {ECO:0000305}.
FT   CONFLICT    697    699       Missing (in Ref. 6; AAI36805/AAI44415).
FT                                {ECO:0000305}.
FT   STRAND       13     24       {ECO:0000244|PDB:3PYC}.
FT   STRAND       36     42       {ECO:0000244|PDB:3PYC}.
FT   TURN         43     45       {ECO:0000244|PDB:3PYC}.
FT   STRAND       48     50       {ECO:0000244|PDB:3PYC}.
FT   STRAND       61     71       {ECO:0000244|PDB:3PYC}.
FT   STRAND       76     82       {ECO:0000244|PDB:3PYC}.
FT   HELIX        83     85       {ECO:0000244|PDB:3PYC}.
FT   TURN         90     93       {ECO:0000244|PDB:3PYC}.
FT   STRAND       94    100       {ECO:0000244|PDB:3PYC}.
FT   HELIX       102    108       {ECO:0000244|PDB:3PYC}.
FT   STRAND      114    117       {ECO:0000244|PDB:3PYC}.
FT   STRAND      131    139       {ECO:0000244|PDB:3PYC}.
FT   STRAND      241    245       {ECO:0000244|PDB:2LAZ}.
FT   TURN        246    248       {ECO:0000244|PDB:2LAZ}.
FT   STRAND      249    254       {ECO:0000244|PDB:2LAZ}.
FT   TURN        255    258       {ECO:0000244|PDB:2LAZ}.
FT   STRAND      259    263       {ECO:0000244|PDB:2LAZ}.
FT   STRAND      312    317       {ECO:0000244|PDB:2LB1}.
FT   TURN        318    320       {ECO:0000244|PDB:2LB1}.
FT   STRAND      321    326       {ECO:0000244|PDB:2LB1}.
FT   TURN        327    330       {ECO:0000244|PDB:2LB1}.
FT   STRAND      331    334       {ECO:0000244|PDB:2LB1}.
SQ   SEQUENCE   757 AA;  86114 MW;  89A171CFC47B40E9 CRC64;
     MSNPGTRRNG SSIKIRLTVL CAKNLAKKDF FRLPDPFAKI VVDGSGQCHS TDTVKNTLDP
     KWNQHYDLYV GKTDSITISV WNHKKIHKKQ GAGFLGCVRL LSNAISRLKD TGYQRLDLCK
     LNPSDTDAVR GQIVVSLQTR DRIGTGGSVV DCRGLLENEG TVYEDSGPGR PLSCFMEEPA
     PYTDSTGAAA GGGNCRFVES PSQDQRLQAQ RLRNPDVRGS LQTPQNRPHG HQSPELPEGY
     EQRTTVQGQV YFLHTQTGVS TWHDPRIPSP SGTIPGGDAA FLYEFLLQGH TSEPRDLNSV
     NCDELGPLPP GWEVRSTVSG RIYFVDHNNR TTQFTDPRLH HIMNHQCQLK EPSQPLPLPS
     EGSLEDEELP AQRYERDLVQ KLKVLRHELS LQQPQAGHCR IEVSREEIFE ESYRQIMKMR
     PKDLKKRLMV KFRGEEGLDY GGVAREWLYL LCHEMLNPYY GLFQYSTDNI YMLQINPDSS
     INPDHLSYFH FVGRIMGLAV FHGHYINGGF TVPFYKQLLG KPIQLSDLES VDPELHKSLV
     WILENDITPV LDHTFCVEHN AFGRILQHEL KPNGRNVPVT EENKKEYVRL YVNWRFMRGI
     EAQFLALQKG FNELIPQHLL KPFDQKELEL IIGGLDKIDL NDWKSNTRLK HCVADSNIVR
     WFWQAVETFD EERRARLLQF VTGSTRVPLQ GFKALQGSTG AAGPRLFTIH LIDANTDNLP
     KAHTCFNRID IPPYESYEKL YEKLLTAVEE TCGFAVE
//
